Our team consisting of Dee LaVigne, Stephen T. Haley and Frank Li will showcase our leading technical solutions focused on high-performance anti-idiotype antibody for precision CAR-T detection. Our detection reagents deliver up to 1:100,000 sensitivity, cover six out of seven mainstream CAR-T targets, and support long-term multi-year in vivo CAR monitoring projects.
At the booth, we will share our full-spectrum preclinical research system for in vivo CAR-T development, covering LNP delivery screening, NHP (Cynomolgus monkey) animal model evaluation, ex-vivo testing platform and completed real-world case data of CD20 in vivo CAR-T verification.
All researchers focused on in vivo CAR-T, solid tumor CAR therapy and preclinical animal validation are warmly invited to stop by Booth #803 for technical discussion and sample consultation.